Dan and colleagues followed antigen-specific antibodies, memory B cells, CD4+ T cells, and CD8+ T cells up to 8 months after recovery from COVID-19 [11], but a more recent study has shown sustained T and B cell responses over a year after infection [12]. The gene discussed is CD4; the disease is COVID-19.